169 related articles for article (PubMed ID: 22326299)
21. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
22. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
Ghera BB; Perret F; Chevalier Y; Parrot-Lopez H
Int J Pharm; 2009 Jun; 375(1-2):155-62. PubMed ID: 19481701
[TBL] [Abstract][Full Text] [Related]
23. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
[TBL] [Abstract][Full Text] [Related]
24. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus.
Pople PV; Singh KK
Eur J Pharm Biopharm; 2011 Sep; 79(1):82-94. PubMed ID: 21447390
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide.
Hassan HA; Al-Marzouqi AH; Jobe B; Hamza AA; Ramadan GA
J Pharm Biomed Anal; 2007 Oct; 45(2):243-50. PubMed ID: 17630246
[TBL] [Abstract][Full Text] [Related]
26. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
27. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W
Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276
[TBL] [Abstract][Full Text] [Related]
28. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system.
Krauland AH; Alonso MJ
Int J Pharm; 2007 Aug; 340(1-2):134-42. PubMed ID: 17459620
[TBL] [Abstract][Full Text] [Related]
29. Preparation of Bovine Serum Albumin (BSA) nanoparticles by desolvation using a membrane contactor: a new tool for large scale production.
Yedomon B; Fessi H; Charcosset C
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):398-405. PubMed ID: 23811438
[TBL] [Abstract][Full Text] [Related]
30. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
[TBL] [Abstract][Full Text] [Related]
31. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection.
Li Q; Li Z; Zeng W; Ge S; Lu H; Wu C; Ge L; Liang D; Xu Y
Eur J Pharm Sci; 2014 Oct; 62():115-23. PubMed ID: 24905830
[TBL] [Abstract][Full Text] [Related]
32. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
[TBL] [Abstract][Full Text] [Related]
33. Formulation and evaluation of nimodipine-loaded lipid microspheres.
Yu J; He HB; Tang X
J Pharm Pharmacol; 2006 Nov; 58(11):1429-35. PubMed ID: 17132204
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin.
Taneri F; Ozcan I; Guneri T
Drug Deliv; 2010 Apr; 17(3):152-7. PubMed ID: 20148713
[TBL] [Abstract][Full Text] [Related]
35. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
Ye J; Wang Q; Zhou X; Zhang N
Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
[TBL] [Abstract][Full Text] [Related]
36. Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin.
Ren K; Zhang Z; Li Y; Liu J; Zhao D; Zhao Y; Gong T
Pharmazie; 2009 Aug; 64(8):515-20. PubMed ID: 19746840
[TBL] [Abstract][Full Text] [Related]
37. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
Ventura CA; Giannone I; Musumeci T; Pignatello R; Ragni L; Landolfi C; Milanese C; Paolino D; Puglisi G
Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393
[TBL] [Abstract][Full Text] [Related]
38. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
Yang ZQ; Xu J; Pan P; Zhang XN
Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
[TBL] [Abstract][Full Text] [Related]
39. Preparation of Tacrolimus loaded micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone).
Wang Y; Wang C; Fu S; Liu Q; Dou D; Lv H; Fan M; Guo G; Luo F; Qian Z
Int J Pharm; 2011 Apr; 407(1-2):184-9. PubMed ID: 21251958
[TBL] [Abstract][Full Text] [Related]
40. Preparation, characterization of hydrophilic and hydrophobic drug in combine loaded chitosan/cyclodextrin nanoparticles and in vitro release study.
Jingou J; Shilei H; Weiqi L; Danjun W; Tengfei W; Yi X
Colloids Surf B Biointerfaces; 2011 Mar; 83(1):103-7. PubMed ID: 21112190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]